Paternal Relatives and Family History of Breast Cancer

American Journal of Preventive Medicine - Tập 31 - Trang 265-268 - 2006
John M. Quillin1,2, Viswanathan Ramakrishnan3,2, Joseph Borzelleca4, Joann Bodurtha1,2, Deborah Bowen5, Diane Baer Wilson2
1Department of Human Genetics, Virginia Commonwealth University, Richmond, Virginia
2Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia
3Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia
4Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, Virginia
5Department of Health Services and Fred Hutchison Cancer Research Center, University of Washington, Seattle, Washington

Tài liệu tham khảo

Khoury, 2003, Genetics and genomics in practice, Genet Med, 5, 261, 10.1097/01.GIM.0000076977.90682.A5 Khoury, 2005, Do we need genomic research for the prevention of common diseases with environmental causes?, Am J Epidemiol, 161, 799, 10.1093/aje/kwi113 Yoon, 2002, Can family history be used as a tool for public health and preventive medicine?, Genet Med, 4, 304, 10.1097/00125817-200207000-00009 Yoon, 2004, Awareness of family health history as a risk factor for disease—United States, 2004, MMWR Morb Mortal Wkly Rep, 53, 1044 Yoon, 2003, Research priorities for evaluating family history in the prevention of common chronic diseases, Am J Prev Med, 24, 128, 10.1016/S0749-3797(02)00585-8 Jemal, 2005, Cancer statistics, 2005, CA Cancer J Clin, 55, 10, 10.3322/canjclin.55.1.10 Smith, 2005, American Cancer Society guidelines for the early detection of cancer, 2005, CA Cancer J Clin, 55, 31, 10.3322/canjclin.55.1.31 Humphrey, 2002, Breast cancer screening, Ann Intern Med, 137, 347, 10.7326/0003-4819-137-5_Part_1-200209030-00012 Burke, 1997, Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Consortium, JAMA, 277, 997, 10.1001/jama.1997.03540360065034 Chlebowski, 2003, American Society of Clinical Oncology Technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitors, J Clin Oncol, 20, 3328, 10.1200/JCO.2002.06.029 Hartmann, 1999, Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer, N Engl J Med, 340, 77, 10.1056/NEJM199901143400201 Anderson, 1974, Genetic study of breast cancer, Cancer, 34, 1090, 10.1002/1097-0142(197410)34:4<1090::AID-CNCR2820340419>3.0.CO;2-J Anderson, 1977, Breast cancer in families, Cancer, 40, 1855, 10.1002/1097-0142(197710)40:4+<1855::AID-CNCR2820400814>3.0.CO;2-1 Claus, 1994, Autosomal dominant inheritance of early-onset breast cancer. implications for prediction, Cancer, 73, 643, 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5 Claus, 1994, Autosomal dominant inheritance of early-onset breast cancer, Cancer, 73, 643, 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5 Gail, 1989, Projecting individualized probabilities of developing breast cancer for white females who are being examined annually, J Natl Cancer Inst, 81, 1879, 10.1093/jnci/81.24.1879 Lichtenstein, 2000, Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland, N Engl J Med, 343, 78, 10.1056/NEJM200007133430201 Ziogas, 2003, Validation of family history data in cancer family registries, Am J Prev Med, 24, 190, 10.1016/S0749-3797(02)00593-7 Love, 1985, The accuracy of patient reports of a family history of cancer, Chronic Dis, 38, 289, 10.1016/0021-9681(85)90074-8 Canter, 2005, Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women, Cancer Res, 65, 8028, 10.1158/0008-5472.CAN-05-1428 Green, 1997, Family communication and genetic counseling, J Genet Counsel, 6, 45, 10.1023/A:1025611818643 Tinley, 1999, Integration of family history and medical management of patients with hereditary cancers, Cancer, 86, 1705, 10.1002/(SICI)1097-0142(19991015)86:8+<1705::AID-CNCR9>3.0.CO;2-K Bowen, 1997, Importance of psychological variables in understanding risk perceptions and breast cancer screening of African American women, Womens Health Res Gender Behav Policy, 3, 227 Hoffrage, 2000, Communicating statistical information, Science, 290, 2261, 10.1126/science.290.5500.2261 Skinner, 1998, Perceived and actual breast cancer risk, J Health Psychol, 3, 181, 10.1177/135910539800300203 King, 2003, Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2, Science, 302, 643, 10.1126/science.1088759 d’Agincourt-Canning, 2001, Experiences of genetic risk, Bioethics, 15, 231, 10.1111/1467-8519.00234 Forrest, 2003, To tell or not to tell, Clin Genet, 64, 317, 10.1034/j.1399-0004.2003.00142.x Tercyak, 2001, Parental communication of BRCA1/2 genetic test results to children, Patient Educ Counsel, 42, 213, 10.1016/S0738-3991(00)00122-1 Bellis, 2005, Measuring paternal discrepancy and its public health consequences, J Epidemiol Community Health, 59, 749, 10.1136/jech.2005.036517 Pinsky, 2003, Reported family history of cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, Am J Epidemiol, 157, 792, 10.1093/aje/kwg043 Glanz, 1999, Underreporting of family history of colon cancer, Cancer Epidemiol Biomarkers Prev, 8, 635